JPS61205261A - ６―置換―５―フルオロウラシル誘導体 - Google Patents

６―置換―５―フルオロウラシル誘導体

Info

Publication number
JPS61205261A
JPS61205261A JP60044621A JP4462185A JPS61205261A JP S61205261 A JPS61205261 A JP S61205261A JP 60044621 A JP60044621 A JP 60044621A JP 4462185 A JP4462185 A JP 4462185A JP S61205261 A JPS61205261 A JP S61205261A
Authority
JP
Japan
Prior art keywords
group
fluoro
added
substituted
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60044621A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0583550B2 (fr
Inventor
Takamasa Fuchigami
渕上　高正
Akiko Yamanouchi
山之内　明子
Mariko Tanaka
田中　マリ子
Kunikazu Sakai
酒井　邦和
Kaoru Yamada
薫 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Priority to JP60044621A priority Critical patent/JPS61205261A/ja
Publication of JPS61205261A publication Critical patent/JPS61205261A/ja
Publication of JPH0583550B2 publication Critical patent/JPH0583550B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60044621A 1985-03-08 1985-03-08 ６―置換―５―フルオロウラシル誘導体 Granted JPS61205261A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60044621A JPS61205261A (ja) 1985-03-08 1985-03-08 ６―置換―５―フルオロウラシル誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60044621A JPS61205261A (ja) 1985-03-08 1985-03-08 ６―置換―５―フルオロウラシル誘導体

Publications (2)

Publication Number Publication Date
JPS61205261A true JPS61205261A (ja) 1986-09-11
JPH0583550B2 JPH0583550B2 (fr) 1993-11-26

Family

ID=12696502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60044621A Granted JPS61205261A (ja) 1985-03-08 1985-03-08 ６―置換―５―フルオロウラシル誘導体

Country Status (1)

Country Link
JP (1) JPS61205261A (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0420763A2 (fr) * 1989-09-29 1991-04-03 Mitsubishi Chemical Corporation Dérivés de nucléosides d'acyclopyrimidines 6-substituées et agent antiviral les contenant comme ingrédients actifs
WO2004014868A3 (fr) * 2002-08-13 2004-06-03 Warner Lambert Co Derives de pyrimidine 2,4-diones, utilises comme inhibiteurs de metalloproteinase matricielle
WO2004087677A3 (fr) * 2003-04-03 2004-12-16 Pharmacia Corp Pyrimidinones substituees
US7217226B2 (en) 2003-02-04 2007-05-15 Mcmillan Electric Company Method and system for coupling a flywheel assembly onto a shaft of an electric motor using a self-holding taper
JP2009522283A (ja) * 2005-12-29 2009-06-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ プロキネチシン１受容体アンタゴニスト
US7795271B2 (en) 2003-04-03 2010-09-14 Pharmacia Corporation Substituted pyrimidinones
US8324230B2 (en) 2004-10-13 2012-12-04 Pfizer Inc. Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6H)-Yl]-N-(2-hydroxyethyl)-4-methylbenzamide
US9181200B2 (en) 2013-06-21 2015-11-10 MyoKardia, Inc. Pyrimidinedione compounds
US9199945B2 (en) 2013-06-21 2015-12-01 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
EP3359154A4 (fr) * 2015-10-08 2019-05-15 Suzhou Yunxuan Yiyao Keji Youxian Gongsi Inhibiteurs de la voie de signalisation wnt et leurs applications thérapeutiques

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0829476A3 (fr) * 1989-09-29 1999-02-24 Mitsubishi Chemical Corporation Dérivés de nucléoside acylopyrimidine 6-substitués et agent antiviral les contenant comme ingrédient actif
EP0420763A2 (fr) * 1989-09-29 1991-04-03 Mitsubishi Chemical Corporation Dérivés de nucléosides d'acyclopyrimidines 6-substituées et agent antiviral les contenant comme ingrédients actifs
WO2004014868A3 (fr) * 2002-08-13 2004-06-03 Warner Lambert Co Derives de pyrimidine 2,4-diones, utilises comme inhibiteurs de metalloproteinase matricielle
US7217226B2 (en) 2003-02-04 2007-05-15 Mcmillan Electric Company Method and system for coupling a flywheel assembly onto a shaft of an electric motor using a self-holding taper
US7563204B2 (en) 2003-02-04 2009-07-21 Mcmillan Electric Company Method and system for coupling a flywheel assembly onto a shaft of an electric motor using a self-holding taper
WO2004087677A3 (fr) * 2003-04-03 2004-12-16 Pharmacia Corp Pyrimidinones substituees
AU2004226165B2 (en) * 2003-04-03 2007-11-08 Pharmacia Corporation Pyrimidin-4-one derivatives and their use as p38 kinase modulators
EA009743B1 (ru) * 2003-04-03 2008-04-28 Фармация Корпорейшн Производные пиримидин-4-она и их применение в качестве модуляторов киназы p38
AU2004226165C1 (en) * 2003-04-03 2008-07-03 Pharmacia Corporation Pyrimidin-4-one derivatives and their use as p38 kinase modulators
US7795271B2 (en) 2003-04-03 2010-09-14 Pharmacia Corporation Substituted pyrimidinones
US8324230B2 (en) 2004-10-13 2012-12-04 Pfizer Inc. Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6H)-Yl]-N-(2-hydroxyethyl)-4-methylbenzamide
JP2009522283A (ja) * 2005-12-29 2009-06-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ プロキネチシン１受容体アンタゴニスト
US9181200B2 (en) 2013-06-21 2015-11-10 MyoKardia, Inc. Pyrimidinedione compounds
US9199945B2 (en) 2013-06-21 2015-12-01 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
US9585883B2 (en) 2013-06-21 2017-03-07 MyoKardia, Inc. Pyrimidinedione compounds
USRE50050E1 (en) 2013-06-21 2024-07-23 MyoKardia, Inc. Pyrimidinedione compounds
EP3359154A4 (fr) * 2015-10-08 2019-05-15 Suzhou Yunxuan Yiyao Keji Youxian Gongsi Inhibiteurs de la voie de signalisation wnt et leurs applications thérapeutiques
US10450300B2 (en) 2015-10-08 2019-10-22 Suzhou Yunxuan Yiyao Keji Youxian Gongsi Wnt signaling pathway inhibitors and therapeutic applications thereof

Also Published As

Publication number Publication date
JPH0583550B2 (fr) 1993-11-26

Similar Documents

Publication Publication Date Title
JPS61205261A (ja) ６―置換―５―フルオロウラシル誘導体
CN115260262A (zh) 一种胞嘧啶叠氮化合物的制备方法
JPS59122470A (ja) キノリン−３−カルボン酸誘導体の製造法
WO2011099443A1 (fr) Composé dérivé de β-dihydrofurane, procédé pour produire un composé dérivé de β-dihydrofurane ou un composé dérivé de β-tétrahydrofurane, composé de β-glycoside, procédé pour produire un composé de β-glycoside, et procédé pour produire le 4'-éthynyl-d4t et des composés analogues de celui-ci
JP2560358B2 (ja) イミダゾール誘導体およびその製法
EP3088391A1 (fr) Procédé de production de dérivé d'ester 2-aminonicotinate de benzyle
CN116041366A (zh) 手性3-螺环氧化吲哚并苯并噻吩砜类衍生物、其制备方法及用途
CN114790212B (zh) 恶嗪并异吲哚和恶嗪并异喹啉化合物及其制备方法
CN110218192B (zh) 一种2-氨基-4,6-二甲氧基嘧啶的制备方法
JP4026233B2 (ja) ４，５−ジクロロ−６−（α−フルオロアルキル）ピリミジンの製法
CN111333651B (zh) 一种含SCF3或SeCF3的杂环化合物及其制备方法
CN101287711A (zh) 1-取代-5-酰基咪唑化合物的制备方法
JP2547634B2 (ja) ２ーアシルー２ーアリールオキシ又はヘテロ環オキシアセトニトリル類およびアミノピラゾール類の製造方法
CN114751909B (zh) 一种瑞博西尼中间体的制备方法
WO2024126771A1 (fr) Procédé de préparation de (z)-3-(2-(5-bromo-1h-indol-3-yl)-2-cyanovinyl)-4-méthoxybenzonitrile
JPH083143A (ja) ６−アラルキル置換ピリミジン誘導体の製造方法
KR102188341B1 (ko) 아픽사반의 제조방법
JPS6011707B2 (ja) １−カルボキシアルキルカルバモイル−５−フルオロウラシル誘導体およびその製造法
Musalova et al. Ethoxytelluration of Terminal Alkenes with Tellurium Tetrahalides
JPH03130280A (ja) ４―アリールオキシ―１，３―ベンゾジオキソール類の製造方法
JPS61287964A (ja) ｔ−ブチル置換フタロシアニン類及びその中間体の製造方法
JPH05247056A (ja) インドロカルバゾール誘導体
JPH0212231B2 (fr)
TWI668220B (zh) 恩替卡韋的合成方法及其中間體化合物
JP4055246B2 (ja) ５−クロロ−６−（α−フルオロアルキル）−４−ピリミドン及びその製法